未登录 Interim report on engineered NK cell trial in lung cancer refractory to immune checkpoint inhibitors 关于对免疫检查点抑制剂耐药的肺癌患者进行的工程化NK细胞试验的中期报告 Villalona-Calero, Miguel A.; Tian, Lei; Li, Xiaochen; Palmer, Joycelynne M.; Aceves, Claudia; Meisen, Hans; Cortez, Catherine; Synold, Timothy W.; Egelston, Colt; Vandeusen, Jeffrey; Bruno, Ivone; Zhang, Lei; Romeu-Bonilla, Eliezer; Butt, Omer; Forman, Stephen J.; Caligiuri, Michael A.; Yu, Jianhua 分享 收藏
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer MEK抑制剂曲美替尼单独或与AKT抑制剂GSK2141795/乌普罗替尼联合治疗转移性三阴性乳腺癌患者的II期研究 Prasath, Vishnu; Boutrid, Hinda; Wesolowski, Robert; Abdel-Rasoul, Mahmoud; Timmers, Cynthia; Lustberg, Maryam; Layman, Rachel M.; Macrae, Erin; Mrozek, Ewa; Shapiro, Charles; Glover, Kristyn; Vater, Mark; Budd, G. Thomas; Harris, Lyndsay; Isaacs, Claudine; Dees, Claire; Perou, Charles M.; Johnson, Gary L.; Poklepovic, Andrew; Chen, Helen; Villalona-Calero, Miguel; Carson, William; Stover, Daniel G.; Ramaswamy, Bhuvaneswari 分享 收藏
First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration5 MTAP缺失的实体瘤患者中MTA合作PRMT5抑制剂AMG 193的首次人体研究: I期剂量探索的结果5 Rodon, J.; Prenen, H.; Sacher, A.; Villalona-Calero, M.; Penel, N.; El Helali, A.; Rottey, S.; Yamamoto, N.; Ghiringhelli, F.; Goebeler, M. E.; Doi, T.; Postel-Vinay, S.; Lin, C. -c.; Liu, C.; Chuang, C. -h.; Keyvanjah, K.; Eggert, T.; Neil, B. h. o ' 分享 收藏
PRELIMINARY RESULTS OF A PHASE I/II TRIAL OF SELINEXOR AND TEMOZOLOMIDE IN RECURRENT GLIOBLASTOMA Chow, Frances; Berens, Michael; Palmer, Joycelynne; Villalona-Calero, Miguel; Ney, Douglas; de la Fuente, Macarena; Jaeckle, Kurt; Kizilbash, Sani H.; Nasany, Ruham Alshiekh; Hrachova, Maya; Porter, Alyx B.; Piccioni, David; Hoang, Kimberly; Lipinski, Lindsay; Strowd, Roy; Giglio, Pierre; Mantica, Megan; Schiff, David; Gore, Steven; Portnow, Jana 分享 收藏
分享 收藏
Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphoma Othman, Tamer; Frankel, Paul; Allen, Pamela; Popplewell, Leslie L.; Shouse, Geoffrey; Siddiqi, Tanya; Danilov, Alexey V.; Ruel, Nora; Daniels, Shari; Peters, Lacolle; Khoo, Stella; Rosen, Steven T.; Sharon, Elad; Villalona-Calero, Miguel; Ruel, Christopher; Tuscano, Joseph; Herrera, Alex F. 分享 收藏
A dose escalation and cohort expansion study of the CDK9 inhibitor KB-0742 in triple negative breast cancer and transcriptionally addicted relapsed or refractory solid tumors Mita, Monica; Mita, Alain; Villalona-Calero, Miguel; Federman, Noah; Rasco, Drew; Spigel, David; Luo, Jia; Cote, Gregory; Cutler, Richard; Kumar, Pavan; MacKenzie, Crystal; Lin, Charles; DiMartino, Jorge; Olek, Elizabeth; Van Tine, Brian 分享 收藏
A novel HLA-DQB2::MET gene fusion variant in lung adenocarcinoma with prolonged response to tepotinib: a case report Dias e Silva, Douglas; Mambetsariev, Isa; Fricke, Jeremy; Babikian, Razmig; Dingal, Shaira Therese; Mazdisnian, Farhad; Badie, Behnam; Arvanitis, Leonidas; Afkhami, Michelle; Villalona-Calero, Miguel; Salgia, Ravi 分享 收藏
Phase II study of trametinib alone and in combination with uprosertib in patients with metastatic triple negative breast cancer previously treated with chemotherapy: OSU 13317 Prasath, Vishnu; Boutrid, Hinda; Mrozek, Ewa; Lustberg, Maryam; Weslowski, Robert; Layman, Rachel; Abdel-Rasoul, Mahmoud; Timmers, Cynthia; MacRae, Erin; Budd, G. Thomas; Harris, Lyndsay; Isaacs, Claudine; Ismail-Khan, Roohi; Dees, Elizabeth Claire; Poklepovic, Andrew S.; Chen, Helen X.; Villalona-Calero, Miguel; Carson, William; Johnson, Gary L.; Stover, Daniel G.; Ramaswamy, Bhuvaneswari 分享 收藏
A dose escalation and cohort expansion study of the CDK9 inhibitor KB0742 in relapsed, refractory ovarian cancer and transcriptionally addicted relapsed or refractory solid tumors Villalona-Calero, Miguel; Mita, Monica; Mita, Alain; Federman, Noah; Rasco, Drew; Spigel, David; Luo, Jia; Cote, Gregory M.; Cutler, Richard E.; Kumar, Pavan; MacKenzie, Crystal J.; Lin, Charles; DiMartino, Jorge F.; Olek, Elizabeth A.; Van Tine, Brian 分享 收藏
Initial results from first-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in biomarker-selected solid tumors Rodon, Jordi; Yamamoto, Noboru; Doi, Toshihiko; Ghiringhelli, Francois; Goebeler, Maria-Elisabeth; Fujuwara, Yutaka; Villalona-Calero, Miguel; Penel, Nicolas; Patnaik, Amita; Machiels, Jean-Pascal; Addeo, Alfredo; Abbruzzese, James; Postel-Vinay, Sophie; Rottey, Sylvie; Liu, Chunxu; Chuang, Chen-Hua; Kormany, William; Hughes, Paul; Keyvanjah, Kiana; O'Neil, Bert 分享 收藏
A first-in-human study of CDK9 inhibitor KB-0742 demonstrates evidence of tolerability and clinical activity Villalona-Calero, Miguel; Mita, Monica; Mita, Alain; Federman, Noah; Rasco, Drew; Spigel, David; Luo, Jia; Hanna, Glenn J.; Cote, Gregory M.; Cutler, Richard E.; Kumar, Pavan; MacKenzie, Crystal; Lin, Charles; DiMartino, Jorge F.; Olek, Elizabeth A.; Van Tine, Brian 分享 收藏
Stereotactic Body Radiation Therapy for Oligoprogressive and Oligorecurrent Non-Small-Cell Lung Cancer Ebadi, Maryam; Ladbury, Colton; Liu, Jason; Rock, Adam; Onyshchenko, Mykola; Villaflor, Victoria; Villalona-Calero, Miguel; Salgia, Ravi; Massarelli, Erminia; Lee, Percy; Williams, Terence; Amini, Arya 分享 收藏
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors Abuzakhm, Sonia M.; Sukrithan, Vineeth; Fruth, Briant; Qin, Rui; Strosberg, Jonathan; Hobday, Timothy J.; Semrad, Thomas; Reidy-Lagunes, Diane; Kindler, Hedy Lee; Kim, George P.; Knox, Jennifer J.; Kaubisch, Andreas; Villalona-Calero, Miguel; Chen, Helen; Erlichman, Charles; Shah, Manisha H. 分享 收藏
分享 收藏
Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21Cip1 promoter Zhu, WG; Srinivasan, K; Dai, ZY; Duan, WR; Druhan, LJ; Ding, HM; Yee, L; Villalona-Calero, MA; Plass, C; Otterson, GA 分享 收藏
分享 收藏
A phase I study of synthetic lethal, IDE397 (MAT2A inhibitor) as a monotherapy and in combination with chemotherapy in advanced solid tumors harboring MTAP deletion Johnson, M. L.; Rodon, J.; Aljumaily, R.; Villalona-Calero, M.; Borazanci, E.; Pishvaian, M.; Turk, A.; Carvajal, R. D.; Mantia, C.; Giaccone, G.; Mounir, Z.; Patel, A.; Maurer, M.; Neilan, C.; Rajendran, D.; Ganesan, U.; Hinkle, J.; Tolcher, A. W. 分享 收藏
Pembrolizumab activity in patients with Fanconi anemia repair pathway competent and deficient tumors Villalona-Calero, Miguel A.; Diaz, John P.; Duan, Wenrui; Diaz, Zuanel; Schroeder, Eric D.; Aparo, Santiago; Gatcliffe, Troy; Albrecht, Federico; Venkatappa, Siddhartha; Guardiola, Victor; Garrido, Sara; Rubens, Muni; DeZarraga, Fernando; Vuong, Hao 分享 收藏
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer Page, Ray D.; Drusbosky, Leylah M.; Dada, Hiba; Raymond, Victoria M.; Daniel, Davey B.; Divers, Stephen G.; Reckamp, Karen L.; Villalona-Calero, Miguel A.; Dix, Daniel; Odegaard, Justin, I; Lanman, Richard B.; Papadimitrakopoulou, Vassiliki A.; Leighl, Natasha B. 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
